FDA Approves Lucentis Biosimilar Nufymco

• by Conexiant News Staff

• January 2, 2026

Marked and reversible circulating insulin-like growth factor-1 elevation during teprotumumab N01 treatment for thyroid eye disease with limited correspondence to glycemic changes

• by Wei Zhao, Lingli Zhou, Ying Gao, Xianghai Zhou, Xueyao Han, Xiuying Zhang, Linong Ji

• July 15, 2026

Retinal Features May Reveal Depression

In a UK Biobank cohort, thinner ganglion cell-inner plexiform layer and macular measurements were associated with incident depression over more than a decade of follow-up, while no independent association emerged for anxiety disorders.

• by Andrea Surnit

• June 11, 2026

• 4 min

Meta-analysis of the association between retinopathy and the risk of stroke

• by Lingyun Wu, Weifeng Jiang

• June 30, 2026